SBFM
VRTX icon

S-Bank Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

S-Bank Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$615K Sell
1,377
-51
-4% -$23.8K 0.09% 114
2025
Q4 		$647K Sell
1,428
-776
-35% -$334K 0.08% 108
2025
Q3 		$863K Sell
2,204
-29
-1% -$12.1K 0.11% 111
2025
Q2 		$994K Sell
2,233
-157
-7% -$72.3K 0.15% 105
2025
Q1 		$1.16M Buy
+2,390
New +$1.11M 0.22% 82

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

S-Bank Fund Management's VRTX Position: Q1 2026 in Review

S-Bank Fund Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3.6% in Q1 2026, selling an estimated $23.8K and leaving 1,377 shares worth $615K. The position accounts for 0.09% of the portfolio, ranked #114.

S-Bank Fund Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.16M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • S-Bank Fund Management held 1,377 shares of Vertex Pharmaceuticals worth $615K as of Q1 2026.
  • S-Bank Fund Management sold 51 Vertex Pharmaceuticals shares in Q1 2026, an estimated $23.8K.
  • Vertex Pharmaceuticals made up 0.09% of S-Bank Fund Management's portfolio in Q1 2026, its #114 holding.
  • S-Bank Fund Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • S-Bank Fund Management's Vertex Pharmaceuticals position peaked at $1.16M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on S-Bank Fund Management's 13F filing for Q1 2026, filed 11 May 2026.